Search

West Pharmaceutical Services Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

353.57 2.25

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

343.43

Max

349.43

Pagrindiniai rodikliai

By Trading Economics

Pajamos

15M

154M

Pardavimai

27M

872M

P/E

Sektoriaus vid.

43.474

56.597

Pelnas, tenkantis vienai akcijai

2.37

Dividendų pajamingumas

0.25

Pelno marža

17.654

Darbuotojai

10,800

EBITDA

-39M

179M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+17.66% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

0.25%

2.18%

Kitas uždarbis

2026-10-22

Kitas dividendų mokėjimo data

2026-11-18

Kita Ex Dividend data

2026-11-11

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-965M

24B

Ankstesnė atidarymo kaina

351.32

Ankstesnė uždarymo kaina

353.57

Naujienos nuotaikos

By Acuity

100%

0%

320 / 339 reitingas Healthcare

West Pharmaceutical Services Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-11 20:01; UTC

News

UBS raised West Pharmaceutical Services' price target to $415, maintaining a "buy" rating. Shares are higher since Thursday's close despite earlier session declines.

2026-09-10 20:51; UTC

West Pharmaceutical Services Inc shares are lower in after-market hours amid challenging broader market conditions and declining existing home sales for August.

2026-09-09 20:07; UTC

West Pharmaceutical Services Inc. trades roughly flat amid a broader market trend, remaining near the lower end of its one-month range.

2026-09-08 23:26; UTC

West Pharmaceutical Services Inc. shares are higher in after-market trading, showing modest gains since Tuesday's close despite no specific news to explain the movement.

2026-09-04 19:36; UTC

West Pharmaceutical Services is declining amid broader market pressure from strong labor data and rising Treasury yields, with shares below their 20-day moving average.

2026-09-03 22:01; UTC

West Pharmaceutical Services shares are higher in after-market trading as Treasury yields decline, easing concerns about rising borrowing costs impacting growth stocks.

2026-09-02 23:51; UTC

West Pharmaceutical Services Inc shares are higher in after-market trading. The move occurs amid a weaker-than-expected ADP payrolls report, easing rate hike concerns.

2026-09-01 23:51; UTC

West Pharmaceutical Services Inc shares are lower in after-hours trading, continuing a downward trend and trading below the 20-day moving average.

2026-08-31 20:07; UTC

News

West Pharmaceutical Services is higher, reflecting institutional trading activity amid expectations for interest rate hikes following the Jackson Hole Economic Symposium.

2026-08-28 23:11; UTC

West Pharmaceutical Services shares are higher in after-market trading, reaching a session high but remaining below their 20-day moving average.

2026-08-27 23:02; UTC

West Pharmaceutical Services Inc shares are higher in after-market hours. The broader market reflects a decline in initial jobless claims, indicating labor market strength.

2026-08-26 19:26; UTC

West Pharmaceutical Services Inc is trading higher amid positive market conditions, despite no specific company news driving today's activity.

2026-08-25 23:26; UTC

West Pharmaceutical Services Inc. shares are trading roughly flat after hours, amid broader market stability following a significant decline in crude oil prices.

2026-08-24 19:51; UTC

West Pharmaceutical Services Inc is trading higher today, remaining near the upper end of its one-month range and above its 20-day moving average.

2026-08-21 23:01; UTC

West Pharmaceutical Services Inc. shares are lower in after-market trading, remaining near the lower end of today's range and the upper end of their one-month range.

2026-08-20 20:06; UTC

West Pharmaceutical Services Inc shares are higher, continuing an upward trend since Wednesday. Broader market trends may be influencing investor sentiment in the life sciences sector.

2026-08-19 20:06; UTC

West Pharmaceutical Services Inc shares are rising amid a positive market backdrop, remaining above their 20-day moving average and near the upper end of their one-month range.

2026-08-18 19:36; UTC

West Pharmaceutical Services Inc. is trading slightly higher, maintaining a routine move within its one-month trading range. No specific news was identified.

2026-08-17 22:55; UTC

West Pharmaceutical Services shares are slightly higher in after-market hours, amid escalating geopolitical tensions and rising crude oil prices affecting market stability.

2026-08-14 23:01; UTC

West Pharmaceutical Services shares are lower in after-market hours, influenced by a decline in U.S. retail sales for July. No specific news was identified.

2026-08-13 23:36; UTC

West Pharmaceutical Services Inc. shares declined after-market, with no specific company news identified. Broader market sentiment may be influenced by unchanged producer prices.

2026-08-12 19:36; UTC

West Pharmaceutical Services is trading higher, supported by a slight increase in the core Consumer Price Index and an optimistic outlook for risk assets.

2026-08-11 19:26; UTC

West Pharmaceutical Services Inc is trading higher today, reflecting a gain since Monday. Market participants are watching upcoming U.S. inflation reports closely.

2026-08-10 23:46; UTC

West Pharmaceutical Services shares are higher in after-market trading, reaching a level near the upper end of their one-month range. No specific news was identified.

2026-08-07 19:46; UTC

West Pharmaceutical Services Inc is trading higher during Friday's session, reflecting market strength. Shares remain above their 20-day moving average despite an earlier pullback.

2026-08-06 20:51; UTC

West Pharmaceutical Services Inc. is roughly flat in after-market hours amid broader market declines and ahead of the upcoming non-farm payrolls report.

2026-08-05 19:56; UTC

West Pharmaceutical Services shares are trading higher amid broader market gains, influenced by recent declines in oil prices and potential supply resolution.

2026-08-04 20:51; UTC

West Pharmaceutical Services shares declined in after-hours trading, shifting downward despite an initial gain. No specific company news was identified for the movement.

2026-08-03 19:46; UTC

News

Citigroup raised its price target on West Pharmaceutical Services to $412, maintaining a Buy rating following strong quarterly results and increased revenue guidance.

2026-07-31 23:01; UTC

News

West Pharmaceutical Services shares are lower in after-market trading despite strong Q2 results and raised full-year guidance, reflecting mixed market sentiment.

Akcijų palyginimas

Kainos pokytis

West Pharmaceutical Services Inc Prognozė

Kainos tikslas

By TipRanks

17.66% į viršų

12 mėnesių prognozė

Vidutinis 407.375 USD  17.66%

Aukščiausias 447 USD

Žemiausias 365 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines West Pharmaceutical Services Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

9 ratings

8

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

320 / 339 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.
help-icon Live chat